Cellosaurus RPC-9 (CVCL_B263)
| Cell line name | RPC-9 |
|---|---|
| Synonyms | RPC9 |
| Accession | CVCL_B263 |
| Resource Identification Initiative | To cite this cell line use: RPC-9 (RRID:CVCL_B263) |
| Comments | Population: Chinese; Han and Japanese. Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa). Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. |
| Sequence variations |
|
| Disease | Lung adenocarcinoma (NCIt: C3512) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_B260 (PC-9) |
| Sex of cell | Male |
| Age at sampling | 45Y |
| Category | Cancer cell line |
| Publications | PubMed=17699786; DOI=10.1158/0008-5472.CAN-07-0681 |
| Cross-references | |
| Cell line databases/resources | cancercelllines; CVCL_B263 |
| Encyclopedic resources | Wikidata; Q54951132 |
| Polymorphism and mutation databases | Cosmic; 1083085 |
| Entry history | |
| Entry creation | 06-Jun-2012 |
| Last entry update | 19-Dec-2024 |
| Version number | 20 |